Kuhlmann Shirley R.'s Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Jan 14, 2025
- Accession no.
- 0001062993-25-000761
- Filed
- Jan 14, 2025
- Trade date
- Jan 10, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $908.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kuhlmann Shirley R.CIK 0001734919 | Officer (EVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | Common Stock | MOption exerciseAcquired | +27,500 | $21.34 | +$586,850 | 146,684 | Direct | |
| Jan 10, 2025 | Common Stock | SSaleDisposed | −21,400 | $32.87 | −$703,418 | 125,284 | Direct | |
| Jan 10, 2025 | Common Stock | SSaleDisposed | −6,100 | $33.64 | −$205,204 | 119,184 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | Common Stock | MOption exerciseDisposed | −27,500 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.